INHIBITION OF GSK-3β IDENTIFIES IT AS A NOVEL THERAPEUTIC...

INHIBITION OF GSK-3β IDENTIFIES IT AS A NOVEL THERAPEUTIC TARGET IN PANCREATIC CANCER.

Ougolkov, A.V., Billadeau, D.D.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
29
Language:
english
Journal:
Pancreas
DOI:
10.1097/00006676-200411000-00128
Date:
November, 2004
File:
PDF, 580 KB
english, 2004
Conversion to is in progress
Conversion to is failed